Vitamin prescription drug market, the advantages of local pharmaceutical companies gradually lost?

When it comes to the major brands of vitamins in the retail market, many people immediately think of pregnant women's vitamin products such as Slimean and Elovie, multi-dimensional element products, health hall natural vitamin E capsules and strength stretch C tablets, etc. , all of which come from the OTC or health care products sector, while the performance of vitamin prescription drugs in the retail market is relatively less analyzed. So how do Rx vitamin products perform at retail terminals? This article will provide an analysis of the sales of vitamin prescription drugs in retail pharmacies through relevant data.
2015, China's vitamin prescription drug market size of 400 million yuan (in terms of terminal retail prices, the same 2), an increase of 7.8 percentage points over 2014, year-on-year growth is accelerating, according to CmH data.
the nature of prescription drugs determines that hospitals are bound to be their most important sales channels. City and county-level hospitals together accounted for 90 percent of total sales of vitamin prescription drugs in 2015, while retail pharmacies accounted for only one-third of the remaining share and are expected to decline in 2016.
retail channels of vitamin D series prescription drugs are most popular with consumers
D prescription drugs dominate the retail market, accounting for more than 90% of the sales share, sales in 2015 reached 380 million yuan, the main sales brands are Rogai quan (osteotisol pills) (32.0%), cover trialone (osteosterol pills) (21.2%) and so on. In second and third place were B vitamin and multivitamin prescription drugs, which each accounted for 3.9% and 1.2% of retail vitamin prescription drugs.domestic enterprises are being quickly chased by foreign enterprises
in 2015, foreign enterprises and domestic enterprises in the vitamin prescription drug retail market performance is uneven, the competition is very fierce. However, looking at the development trend in the past two years, we can see that the share of sales of foreign enterprises is rising steadily, while the share of domestic enterprises is relatively decreasing, indicating that foreign enterprises are eating into the retail market of vitamin prescription drugs for domestic enterprises.
specifically, foreign companies accounted for only one share of the retail terminal data for six types of vitamin prescription drugs, both vitamin D and multivitamins. Among them, foreign enterprises in vitamin D prescription drugs with 50.2% share slightly better than domestic enterprises, the rest of the sub-categories are dominated by domestic capital.
However, from the 2013-2015 retail sales data for vitamin D and multivitamin prescription drugs, it can be seen that the market share of foreign enterprises in both categories is increasing year by year, especially in the multivitamin sector, the share of foreign enterprises jumped from 12.8% to 36.7% in 2014-2015, the share growth of 23.9 percentage points, the growth momentum is very rapid. (New Kangjie)